IMPACT Q&A
What is IMPACT?
IMPACT is derived from “Icosapent Ethyl for the Management and Prevention of Atherosclerotic Cardiovascular Disease Trial.” The IMPACT Pilot will reach out to 60,000 Americans to determine the feasibility of conducting a large-scale clinical trial.
What is icosapent ethyl?
Icosapent ethyl is a highly purified form of a type omega-3 fatty acids (icosapentaenoic acid) found in fish or ‘fish oil’.
Will I receive icosapent ethyl or fish oil as part of the pilot study?
No, you will not receive any study medication as part of IMPACT Pilot. If funded by the NIH, you will be contacted about participation in the future trial.
Who is running IMPACT?
IMPACT is run by Brigham and Women’s Hospital, an affiliate of Harvard Medical School, in Boston, MA.
Who is eligible to participate in IMPACT?
Adults 18 and older that have had a heart attack, stroke, blocked arteries in the legs or other arteries OR have had diabetes for more than three years OR have at least three risk factors for cardiovascular disease.
What does participation in the IMPACT Pilot involve?
Completion of a brief screening questionnaire is the only requirement of the IMPACT Pilot.
Why did you ask for access to my medical records?
We would like to confirm whether self-report (what you indicate in the questionnaire) is also confirmed in the medical record. This will show that study participants can provide reliable clinical data. This is an important but OPTIONAL part of the IMPACT Pilot.
Will I be able to participate in the future IMPACT Study?
If deemed eligible by the screening questionnaire, you will be contacted for further participation if the IMPACT Trial receives funding for a large-scale trial from the National Institutes of Health.
What is RedCap?
RedCap is a secure data collection tool created by Vanderbilt University. We use this tool to collect questionnaire data online, and any data is encrypted for your safety.